Low-back pain in HTLV-I-associated myelopathy/tropical spastic paraparesis: Nociceptive or neuropathic

Spinal Cord

Volumn 48, Issue 2, 2010, Pages 134-137

  Tavares, I R ^a   Franzoi, A C ^a,b   Araujo A Q C ^a,c  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Brazilian Beneficent Association of Rehabilitation (ABBR)   (Brazil)

^c Funda??o Oswaldo Cruz   (Brazil)

Author keywords

HTLV I; Low back pain; Myelopathy

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BURN; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; JUMPING; LEG PAIN; LIMB; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; NEUROPATHIC PAIN; NOCICEPTION; PAIN ASSESSMENT; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; SHORT FORM 36; SPASTIC PARESIS; SPINAL CORD DISEASE; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; BRAZIL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; LOW BACK PAIN; LOWER EXTREMITY; MALE; MIDDLE AGED; NOCICEPTORS; PAIN MEASUREMENT; PARAPARESIS, TROPICAL SPASTIC; PREVALENCE; YOUNG ADULT;

EID: 76649127065     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2009.83     Document Type: Article

References (25)

1. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031-1032. (Pubitemid 16102987)
2. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407-410.
3. Figueiroa FL, Andrade Filho AS, Crvalho ES, Brites C, Badaro R. HTLV-I associated myelopathy: clinical and epidemiological profile. Braz J Infect Dis 2000; 4: 126-130.
4. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353: 1951-1958.
5. Carneiro-Proietti AB, Ribas JG, Catalan-Soares BC, Martins ML, Brito-Melo GE, Martins-Filho OA et al. Infection and disease caused by the human T cell lymphotropic viruses type I and II in Brazil]. Rev Soc Bras Med Trop 2002; 35: 499-508.
6. Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Blattner W (ed). Human Retrovirology: HTLV, 1st edn. Raven Press: New York, 1990. pp 191-197.
7. Davidson M, Keating JL. A comparison of five low back disability questionnaires: reliability and responsiveness. Phys Ther 2002; 82: 8-24.
8. Araujo Ade Q, Alfonso CR, Schor D, Leite AC, de Andrada-Serpa MJ. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil. Acta Neurol Scand 1993; 88: 59-62.
9. Franzoi AC, Araujo AQ. Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP). Spinal Cord 2007; 45: 64-68.
10. Franzoi AC, Araujo AQ. Disability profile of patients with HTLV-Iassociated myelopathy/tropical spastic paraparesis using the Functional Independence Measure (FIM). Spinal Cord 2005; 43: 236-240.
11. Gotuzzo E, Cabrera J, Deza L, Verdonck K, Vandamme AM, Cairampoma R et al. Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis. Clin Infect Dis 2004; 39: 939-944.
12. Gotuzzo E, De Las Casas C, Deza L, Cabrera J, Castaneda C, Watts D. Tropical spastic paraparesis and HTLV-I infection: clinical and epidemiological study in Lima, Peru. J Neurol Sci 1996; 143: 114-117.
13. Melo A, Gomes I, Mattos K. [HTLV-1 associated myelopathies in the city of Salvador, Bahia]. Arq Neuropsiquiatr 1994; 52: 320-325.
14. Podsiadlo D, Richardson S. The timed 'Up & Go': a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39: 142-148.
15. Revill SI, Robinson JO, Rosen M, Hogg MI. The reliability of a linear analogue for evaluating pain. Anaesthesia 1976; 31: 1191-1198.
16. Ware Jr JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
17. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114: 29-36.
18. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1: 277-299.
19. Bucher B, Poupard JA, Vernant JC, DeFreitas EC. Tropical neuromyelopathies and retroviruses: a review. Rev Infect Dis 1990; 12: 890-899.
20. Roman GC. The neuroepidemiology of tropical spastic paraparesis. Ann Neurol 1988; 23(Suppl): S113-S120.
21. Osame M, Igata A, Matsumoto M. HTLV-1-associated myelopathy (HAM) revisited. In: Román G, Vernant J, Osame M (eds). HTLV-1 and the Nervous System. Alan R Liss: New York, 1989, pp 213-223.
22. Montgomery RD. HTLV-1 and tropical spastic paraparesis. 1. Clinical features, pathology and epidemiology. Trans R Soc Trop Med Hyg 1989; 83: 724-728.
23. World Health Organization. Cancer Pain Relief and Palliative Care. WHO: Geneva, 1990.
24. Warms CA, Turner JA,Marshall HM, Cardenas DD. Treatments for chronic pain associated with spinal cord injuries: many are tried, few are helpful. Clin J Pain 2002; 18: 154-163.
25. Donnelly C, Eng JJ. Pain following spinal cord injury: the impact on community reintegration. Spinal Cord 2005; 43: 278-282.